Literature DB >> 12477165

Differences in rates of obstructive lung disease between Africans and African Americans.

Irene M Gathuru1, Clareann H Bunker, Flora A Ukoli, Eruke E Egbagbe.   

Abstract

OBJECTIVE: The prevalence of obstructive lung disease is rising in the United States, particularly among those of African descent. Rates of ventilatory impairment and reported respiratory symptoms were examined in a cross-sectional study of urban Nigerian civil servants who are in transition to a westernized lifestyle.
DESIGN: 410 civil servants (235 men, 175 women) aged 30-69 years in Benin City, Nigeria (West Africa) were recruited for a cross-sectional study on respiratory health and compared to 3,397 African Americans enrolled in NHANES III between 1988 and 1994.
METHODS: Forced vital capacity (FVC), expiratory flow rate in 1 sec (FEV1), FEV1/FVC ratio, and peak expiratory flow rate (PEFR) were measured by spirometry. Demographic characteristics and respiratory symptoms were ascertained by questionnaire.
RESULTS: Nigerians had lower age and height adjusted FVC and FEV1 than African Americans in both genders, independent of smoking and respiratory disease. However, relative lung function was better among Nigerians. Fewer Nigerians had an age-adjusted FEV1/FVC ratio below 0.70 than African Americans (10.54 vs 14.10/100 men, 6.29 vs 8.67/100 women). Overall, Nigerians had a lower age-adjusted prevalence of any self-reported respiratory symptoms than African Americans (3.65 vs 22.90/100 men, 4.57 vs 35.38/100 women). Similarly, Nigerians had a lower age-adjusted prevalence of current smoking than African Americans (10.82 vs 46.50/100 in men and 0 vs 30.93/100 in women).
CONCLUSIONS: Urban Nigerians who have limited exposure to cigarette smoke and who work in a non-industrial setting have a low prevalence of obstructive lung disease.

Entities:  

Mesh:

Year:  2002        PMID: 12477165

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  5 in total

1.  Estimating the prevalence of COPD in an African country: evidence from southern Nigeria.

Authors:  Boni M Ale; Obianuju B Ozoh; Muktar A Gadanya; Yiyang Li; Michael O Harhay; Akindele O Adebiyi; Davies Adeloye
Journal:  J Glob Health Rep       Date:  2022-09-15

2.  Prevalence of obstructive lung disease in an African country using definitions from different international guidelines: a community based cross-sectional survey.

Authors:  Eric Walter Pefura-Yone; André Pascal Kengne; Adamou Dodo Balkissou; Christiane Gaelle Magne-Fotso; Martine Ngo-Yonga; Julie Raïcha Boulleys-Nana; Nelly Rachel Efe-de-Melingui; Patricia Ingrid Ndjeutcheu-Moualeu; Charles Lebon Mbele-Onana; Elvira Christelle Kenmegne-Noumsi; Barbara Linda Kolontchang-Yomi; Boris Judicaël Theubo-Kamgang; Emilienne Régine Ebouki; Chrystelle Karen Djuikam-Kamga; Francine Amougou; Liliane Mboumtou; Elsie Linda Petchou-Talla; Christopher Kuaban
Journal:  BMC Res Notes       Date:  2016-02-25

3.  Prevalence and correlates of chronic obstructive pulmonary disease and chronic respiratory symptoms in rural southwestern Uganda: a cross-sectional, population-based study.

Authors:  Crystal M North; Bernard Kakuhikire; Dagmar Vořechovská; Simone Hausammann-Kigozi; Amy Q McDonough; Jordan Downey; David C Christiani; Alexander C Tsai; Mark J Siedner
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

4.  Chronic obstructive pulmonary disease in sub-Saharan Africa.

Authors:  B I Awokola; G A Amusa; C P Jewell; G Okello; M Stobrink; L J Finney; N Mohammed; A Erhart; K J Mortimer
Journal:  Int J Tuberc Lung Dis       Date:  2022-03-01       Impact factor: 3.427

Review 5.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.